Copertina

Barriers and Facilitators to Pharmacist‐Led Deprescribing of Antihypertensives in Long‐Term Care: A Survey‐Based Study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ana Vucenovic, Roni Y. Kraut, Donna P. Manca, Cheryl A. Sadowski
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Basic & Clinical Pharmacology & Toxicology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Supporting Nurse Participation in Deprescribing: A Qualitative Study of Long‐Term Care Nurses in Alberta, Canada
di: Jude Spiers, et al.
Pubblicazione: (2026)

Evaluation of a Pharmacist‐Led Intervention Focused on the Deprescribing of Cardiovascular and Antidiabetic Medication in Older Patients With Polypharmacy: Patients' and Pharmacists' Experiences
di: Jamila Abou, et al.
Pubblicazione: (2026)

Community Pharmacists' Role in Antidepressant Discontinuation: A Survey of Barriers and Facilitators
di: Ketura Verheye, et al.
Pubblicazione: (2026)

Tailoring an Implementation Strategy for Deprescribing as Part of a Comprehensive Geriatric Assessment (dCGA) in Long‐Term Care Facilities: A Roundtable Discussion
di: Dora Belec, et al.
Pubblicazione: (2026)

Perspectives on the Influence of Pharmaceutical and MedTech Companies on Deprescribing Decisions and Conference Sponsorship: A Survey Study
di: Katharina Tabea Jungo, et al.
Pubblicazione: (2025)

Evaluation of the Perception of Deprescribing by French Pharmacy Students: A National Observational Study
di: Jean‐François Huon, et al.
Pubblicazione: (2026)

Patients' Attitudes Towards Deprescribing Differ Across Specific Cardiovascular and Diabetes Medication: A Survey Study Assessing Within‐Patient Differences
di: Peter J. C. Stuijt, et al.
Pubblicazione: (2025)

Billing Deprescribing Interventions: Portrait of an Initiative in Québec, Canada
di: Alexandre Campeau Calfat, et al.
Pubblicazione: (2025)

Development of a Deprescribing Intervention for Proton Pump Inhibitors in Primary Care: A Co‐Design Approach With General Practitioners and Patients
di: Kristie Rebecca Weir, et al.
Pubblicazione: (2025)

Facilitating the Implementation of Physician‐Led Medication Reviews for Patients With Severe Mental Disorder and Diabetes: A Cost‐Minimization Analysis
di: Johan Frederik Mebus Meyer Christensen, et al.
Pubblicazione: (2025)

Patients' Attitudes Towards Deprescribing and Associations With Patient‐Related Factors Across Two Hospital Settings
di: Louise Westberg Strejby Christensen, et al.
Pubblicazione: (2026)

Learnings From a Knowledge Mobilization Strategy to Integrate a Deprescribing Educational Curriculum Into Health Professional Programmes
di: Tiphaine Pierson, et al.
Pubblicazione: (2026)

Supporting Medication Appropriateness Among Indigenous Peoples in Canada: Reflections on the Development and Implementation of a Network Action Plan
di: Amber Ruben, et al.
Pubblicazione: (2025)

Long‐Term Safety and Efficacy of AAV9 Vectors Expressing Human SMN1 Gene: A Preclinical Study
di: Vahid Mansouri, et al.
Pubblicazione: (2025)

Adherence in the Treatment of Inflammatory Bowel Disease With Particular Focus on the Importance of the Clinical Pharmacist: A Systematic Review
di: Faria Sayed, et al.
Pubblicazione: (2025)

Insights Into Gut Barrier Dysfunction and Metabolic Alterations in Mycophenolate‐Induced Enteropathy
di: Clarisse Brossier, et al.
Pubblicazione: (2026)

Prevalence of Patients Admitted to Intensive Care After Administration of Chlordiazepoxide in the Emergency Room
di: Jakob Nørgaard Henriksen, et al.
Pubblicazione: (2025)

Electrochemical Point‐of‐Care Test for Assessing Serum Paracetamol Concentration: Comparison With Traditional Methods and Detection of Concomitant Drugs
di: Johanna K. Kujala, et al.
Pubblicazione: (2025)

Sex differences among patients with intentional poisoning presenting to the emergency Department at a Tertiary Care Centre in Beirut, Lebanon
di: Tharwat El Zahran, et al.
Pubblicazione: (2024)

Fall Risk Awareness and Experiences Among Adult Users of Opioids in Denmark: A Community Pharmacy‐Based Questionnaire Pilot Study
di: Juliane Maria Rosendahl, et al.
Pubblicazione: (2026)

BCPT 2026 Policy for Experimental and Clinical Studies
di: Pernille Tveden‐Nyborg, et al.
Pubblicazione: (2025)

Levothyroxine Treatment During Pregnancy: A Metabolomics Study
di: Olli Kärkkäinen, et al.
Pubblicazione: (2026)

Long‐term stability of five atypical antipsychotics (risperidone, olanzapine, paliperidone, clozapine, quetiapine) and the antidepressant mirtazapine in human serum assessed by a validated SPE LC–MS/MS method
di: Palle Bach Nielsen Fruekilde, et al.
Pubblicazione: (2024)

Healthcare Providers' Perspectives on Antidepressant Discontinuation: A Focus Group Study
di: S. Bouarfa, et al.
Pubblicazione: (2025)

Addressing Improper Medicine Storage Practices: Commentary on Louhisalmi et al.'s Study
di: Shu‐Wen Cheng, et al.
Pubblicazione: (2025)

Association Between Furosemide and Risk of Parkinson's Disease in a Nested Case–Control Study
di: Barkat Babar, et al.
Pubblicazione: (2026)

‘This Is My Decision’: A Qualitative Study of Individuals' Perspectives on Use of Semaglutide for Weight Loss
di: Trine Graabæk, et al.
Pubblicazione: (2025)

Proton Pump Inhibitors and Biomarkers of Haemostasis in Postmenopausal Women: The Buffalo OsteoPerio Study
di: Ahmed I. Soliman, et al.
Pubblicazione: (2025)

Maternal Demographic Patterns in Medication use During Pregnancy: A Nationwide Register Study
di: Mette Østergaard Thunbo, et al.
Pubblicazione: (2025)

Poisonings With Opioids and Benzodiazepines in Denmark: A Retrospective Study From the Danish Poison Information Centre
di: Alba K. V. Sigfredsson, et al.
Pubblicazione: (2025)

Pharmacokinetics of Perampanel in Danish Paediatric Patients With Epilepsy Based on Therapeutic Drug Monitoring
di: Sara Angelucci, et al.
Pubblicazione: (2026)

Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction
di: Ana M. Briones, et al.
Pubblicazione: (2025)

Managing Delayed or Missed Doses of Prolonged‐Release Tacrolimus in Transplant Recipients: Implications for Drug Exposure and Recovery Strategies
di: S. Arraki Zava, et al.
Pubblicazione: (2025)

Analgesic Overdose in Patients With Dental Pain. A Cross‐Sectional Study in Two Dental Emergency Clinics
di: Sofie Krahl Larsen, et al.
Pubblicazione: (2025)

The Incidence of Benzodiazepine and Benzodiazepine‐Related Drug Use in People With and Without Parkinson's Disease—A Nationwide Cohort Study
di: Veera Lonka, et al.
Pubblicazione: (2025)

Protective Effects of Baicalein and Bergenin Against Gentamicin‐Induced Hepatic and Renal Injuries in Rats: An Immunohistochemical and Biochemical Study
di: Fazile Nur Ekinci Akdemir, et al.
Pubblicazione: (2024)

Antidepressants Use Among Pregnant Women in Denmark From 2001 to 2023: A Population‐Level Drug Utilization Study
di: Anne‐Johanne Andersen, et al.
Pubblicazione: (2025)

Trends in Antithrombotic Therapy Initiation Among Patients With Stroke Pre‐ and Post–COVID‐19 in Sweden—An Interrupted Time Series Study
di: Salar Mousa, et al.
Pubblicazione: (2026)

PGI Score: A Promising Alternative to Serum Cholinesterase for Predicting Mortality and Adverse Outcomes in Acute Organophosphorus Poisoning: A Cross‐Sectional Study
di: Ghada Attia Sagah, et al.
Pubblicazione: (2025)

Drug‐Induced Liver Injury Associated With Moxifloxacin: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System and a Real‐World Retrospective Study
di: Yanqing Song, et al.
Pubblicazione: (2025)